E. Fatta

发表

Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP).

A. Craxì, S. Petta, V. Calvaruso, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

E. Taioli, S. Fargion, A. Fracanzani, 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown

S. Fargion, M. Vecchi, A. Fracanzani, 2022, Nutrients.

Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients.

S. Aricó, S. Fargion, A. Fracanzani, 2004, Alcohol and alcoholism.

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.

G. Marchesini, D. Consonni, E. Bugianesi, 2011, Journal of hepatology.

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.

H. Tjalsma, B. Motta, L. Valenti, 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

L. N. Valenti, M. Stazi, S. Fargion, 2005, Blood cells, molecules & diseases.

Hepcidin resistance in dysmetabolic iron overload

D. Girelli, A. Castagna, S. Fargion, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Liver, Pancreas and Bilary Tract I susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary

E. Taioli, L. Valenti, S. Fargion, 2003 .

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

L. N. Valenti, G. Marchesini, E. Bugianesi, 2008, Hepatology.

EFFECTIVENESS OF ENTECAVIR FOR THE TREATMENT OF NUC-NAÏVE CHRONIC HEPATITIS B PATIENTS: A LARGE MULTICENTER COHORT STUDY IN CLINICAL PRACTICE

P. Lampertico, M. Brunetto, S. Fargion, 2009 .

755 5-YEAR ENTECAVIR TREATMENT IN NUC-NAÏVE, FIELD-PRACTICE PATIENTS WITH CHRONIC HEPATITIS B SHOWED EXCELLENT VIRAL SUPPRESSION AND SAFETY PROFILE BUT NO PREVENTION OF HCC IN CIRRHOTICS

M. Colombo, G. Spinzi, M. Strazzabosco, 2013 .

Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease.

E. Taioli, S. Fargion, A. Fracanzani, 2001, Journal of hepatology.

A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.

L. N. Valenti, S. Rovida, S. Fargion, 2014, World journal of gastroenterology.

Maintained viral suppression and excellent safety profile of entecavir monotherapy in 418 NUC-naive patients with chronic hepatitis B : a 4-year field practice, multicenter study

P. Narciso, G. Spinzi, P. Lampertico, 2012 .

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.

D. Swinkels, H. Tjalsma, B. Motta, 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

522 MAINTAINED VIRAL SUPPRESSION AND EXCELLENT SAFETY PROFILE OF ENTECAVIR MONOTHERAPY IN 418 NUC-NAÏVE PATIENTS WITH CHRONIC HEPATITIS B: A 4-YEAR FIELD PRACTICE, MULTICENTER STUDY

M. Colombo, G. Spinzi, P. Lampertico, 2012 .

Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades.

L. N. Valenti, S. Fargion, L. Burdick, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.